Clearpoint Neuro Inc
(CLPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,754 | -11,863 | -6,026 | -18,914 | -13,528 |
| Depreciation Amortization | 1,446 | 981 | 334 | 1,954 | 1,483 |
| Accounts receivable | 497 | 237 | 846 | -1,206 | -157 |
| Other Working Capital | -2,443 | -2,408 | -2,605 | 1,399 | -359 |
| Other Operating Activity | 6,409 | 4,329 | 1,279 | 7,817 | 4,854 |
| Operating Cash Flow | $-11,845 | $-8,724 | $-6,172 | $-8,950 | $-7,707 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -473 | -274 | -183 | -275 | -12 |
| Investing Cash Flow | $-473 | $-274 | $-183 | $-275 | $-12 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 28,653 | 28,653 | N/A | -10,000 | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -10,000 |
| Common Stock Issued | 3,623 | 3,623 | 21 | 16,613 | 16,492 |
| Other Financing Activity | -1,661 | -1,661 | -1,383 | -424 | -340 |
| Financing Cash Flow | $30,615 | $30,615 | $-1,362 | $6,189 | $6,152 |
| Beginning Cash Position | 20,104 | 20,104 | 20,104 | 23,140 | 23,140 |
| End Cash Position | 38,401 | 41,721 | 12,387 | 20,104 | 21,573 |
| Net Cash Flow | $18,297 | $21,617 | $-7,717 | $-3,036 | $-1,567 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,845 | -8,724 | -6,172 | -8,950 | -7,707 |
| Capital Expenditure | -473 | -274 | -183 | -275 | -12 |
| Free Cash Flow | -12,318 | -8,998 | -6,355 | -9,225 | -7,719 |